As shares plunge, Teva sees 7,000 layoffs by year's end | The Times of Israel
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Teva Reports Second Quarter 2020 Financial Results | Business Wire
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.